We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
First Busey Corp
BUSE
$2.58B
| $1.7M | ﹤0.01% |
66,108
+37,441
| +131% | +$884K |
|
1302
Stepan Co
SCL
$1.48B
| $1.7M | ﹤0.01% |
13,335
-2,496
| -16% | -$309K |
|
1303
PetMed Express
PETS
$43.4M
| $1.69M | ﹤0.01% |
48,121
-36,564
| -43% | -$1.27M |
|
1304
United Airlines
UAL
$41B
| $1.69M | ﹤0.01% |
29,423
+22,618
| +332% | +$1.1M |
|
|
BCOV
1305
DELISTED
Brightcove, Inc.
BCOV
| $1.69M | ﹤0.01% |
84,077
+50,687
| +152% | +$1.02M |
|
|
ZEN
1306
DELISTED
ZENDESK INC
ZEN
| $1.69M | ﹤0.01% |
12,782
-606
| -5% | -$86.8K |
|
1307
Midland States Bancorp
MSBI
$698M
| $1.68M | ﹤0.01% |
60,613
+1,332
| +2% | +$30.9K |
|
1308
Insmed
INSM
$27.6B
| $1.68M | ﹤0.01% |
49,310
| – | – |
|
1309
Astec Industries
ASTE
$975M
| $1.67M | ﹤0.01% |
22,202
-175
| -0.8% | -$11.9K |
|
1310
Univest Financial
UVSP
$1.19B
| $1.67M | ﹤0.01% |
58,555
+34,907
| +148% | +$885K |
|
1311
Bruker
BRKR
$8.83B
| $1.67M | ﹤0.01% |
26,256
-5,490
| -17% | -$330K |
|
1312
OSI Systems
OSIS
$3.77B
| $1.67M | ﹤0.01% |
17,399
-1,981
| -10% | -$188K |
|
1313
StoneCo
STNE
$2.49B
| $1.66M | ﹤0.01% |
+27,137
| New | +$2.12M |
|
1314
Iron Mountain
IRM
$37.7B
| $1.65M | ﹤0.01% |
44,666
-155,514
| -78% | -$5.2M |
|
1315
National Beverage
FIZZ
$2.93B
| $1.64M | ﹤0.01% |
33,616
+476
| +1% | +$24.7K |
|
1316
Trex
TREX
$5.1B
| $1.63M | ﹤0.01% |
17,849
-8,107
| -31% | -$762K |
|
|
CAMP
1317
DELISTED
CalAmp Corp.
CAMP
| $1.63M | ﹤0.01% |
6,545
+2,117
| +48% | +$537K |
|
1318
OceanFirst Financial
OCFC
$1.88B
| $1.63M | ﹤0.01% |
68,182
+43,839
| +180% | +$943K |
|
|
AXON
1319
Axon Enterprise
AXON
$50B
| $1.63M | ﹤0.01% |
11,451
-38
| -0.3% | -$5.92K |
|
1320
Coherus Oncology
CHRS
$176M
| $1.63M | ﹤0.01% |
111,540
+16,187
| +17% | +$275K |
|
|
BFS
1321
Saul Centers
BFS
$865M
| $1.63M | ﹤0.01% |
40,555
+6,310
| +18% | +$224K |
|
1322
Avis
CAR
$4.84B
| $1.62M | ﹤0.01% |
22,343
-126,179
| -85% | -$6.52M |
|
1323
Ambarella
AMBA
$3.6B
| $1.62M | ﹤0.01% |
16,128
+5,966
| +59% | +$649K |
|
|
DBD
1324
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.61M | ﹤0.01% |
114,300
-40,586
| -26% | -$559K |
|
1325
Insulet
PODD
$10.2B
| $1.61M | ﹤0.01% |
6,168
-1,237
| -17% | -$331K |
|
Similar funds
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.